Cell Biology and Tissue Engineering
A section of Life (ISSN 2075-1729).
Section Information
Research papers published in this Section will center on the application of biological and engineering principles to understand and control cell and tissue behavior. We encourage the submission of works focused on cellular mechanics and cell signaling, how cells organize and modulate their activities, biosystems engineering and computational biology, bioMEMS and gene chips, functional tissue engineering and biomaterials, and tissue structure–function and cell–matrix interactions.
Topics of interest include but are not limited to:
- Cell biology
- Cellular mechanics
- Tissue engineering
- Biomaterial
- Cell-based therapy
- Cell techniques
- Cell and tissue culture
- Cell growth and differentiation
- Cell death
- Cellular organizations and communications
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Exosomes: Biogenesis, Biologic Function and Clinical Potential (Deadline: 15 July 2022)
- Frontiers in the Evolution and Engineering of Cellular Transporters and Receptors (Deadline: 20 July 2022)
- Gene Regulation by HIFs under Hypoxia (Deadline: 31 July 2022)
- Cell-Based Immunotherapy of Cancer (Deadline: 20 August 2022)
- Cell Culture and Genome Modification Technologies: from Biology to Biomedical Applications (Deadline: 31 August 2022)
- Cancer Biology: Human and Animal Medicine Allied in Fighting Cancer (Deadline: 16 September 2022)
- Cancer Cell Metastasis: In Vitro and In Vivo Approaches (Deadline: 15 October 2022)
- Cell-Cell Junctions in Adhesion, Signaling and Beyond (Deadline: 30 October 2022)
- Recent Advances in Synthetic Immunology (Deadline: 15 November 2022)
- Photodynamic Diagnosis and Therapy (Deadline: 30 November 2022)
- Apoptosis and Autophagy (Deadline: 9 December 2022)
- Human Mesenchymal (hMSC) and Induced Pluripotent (hiPSC) Stem Cells (Deadline: 31 December 2022)
- Natural Killer (NK) Cells: From Virology to Cancer Immunotherapy (Deadline: 10 February 2023)
- Targeting the Gut/Brain Axis in Inflammatory Disorders (Deadline: 28 February 2023)